Evidence-Based Benefits
- IBS symptom relief — Whorwell et al. (2006, n=362) found B. infantis 35624 at 1 billion CFU/day significantly reduced abdominal pain, bloating, and bowel dysfunction vs placebo across all IBS subtypes
- Immune support — B. lactis BB-12 increased secretory IgA and improved immune markers in multiple RCTs; Rizzardini et al. (2012, n=211) showed it enhanced immune response to influenza vaccination
- Bowel regularity — B. lactis HN019 reduced whole gut transit time by 31% in functionally constipated adults (Waller et al., 2011, n=100)
- Gut-brain axis — Allen et al. (2016, n=22) showed B. longum 1714 reduced stress-related cortisol output and subjective anxiety in healthy volunteers